These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10312255)

  • 21. Principles of economic evaluation of health programmes.
    Drumond MF; Stoddart GL
    World Health Stat Q; 1985; 38(4):355-67. PubMed ID: 3938108
    [No Abstract]   [Full Text] [Related]  

  • 22. Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues.
    Coyle D
    Health Econ; 2003 Feb; 12(2):159-62; discussion 163-4. PubMed ID: 12563663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.
    Rutstein SE; Price JT; Rosenberg NE; Rennie SM; Biddle AK; Miller WC
    Glob Public Health; 2017 Oct; 12(10):1269-1281. PubMed ID: 27141969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodological considerations in the analysis of cost effectiveness in dentistry.
    Antczak-Bouckoms AA; Tulloch JF; White BA; Capilouto EI
    J Public Health Dent; 1989; 49(4):215-22. PubMed ID: 2509689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Hill SR; Olson LG; Falck-Ytter Y; Cruz AA; Atkins D; Baumann M; Jaeschke R; Woitalla T; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):251-5. PubMed ID: 23256167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources.
    Sendi P; Al MJ; Gafni A; Birch S
    Soc Sci Med; 2003 Dec; 57(11):2207-15. PubMed ID: 14512250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reflecting the real value of health care resources in modelling and cost-effectiveness studies-The example of viral load informed differentiated care.
    Revill P; Walker S; Cambiano V; Phillips A; Sculpher MJ
    PLoS One; 2018; 13(1):e0190283. PubMed ID: 29293611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic aspects of clinical decision making: applications in patient care.
    Oster G
    Am J Hosp Pharm; 1988 Mar; 45(3):543-7. PubMed ID: 3130753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of health programmes: application of the principles in developing countries.
    Mills A
    World Health Stat Q; 1985; 38(4):368-82. PubMed ID: 3938109
    [No Abstract]   [Full Text] [Related]  

  • 31. Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine.
    Paulden M; O'Mahony JF; McCabe C
    Pharmacoeconomics; 2017 Jan; 35(1):5-13. PubMed ID: 27943173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative cost-benefit analysis of tele-homecare for community-dwelling elderly in Japan: Non-Government versus Government Supported Funding Models.
    Akiyama M; Abraham C
    Int J Med Inform; 2017 Aug; 104():1-9. PubMed ID: 28599810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The concept of cost in the economic evaluation of health care. A theoretical inquiry.
    Johannesson M
    Int J Technol Assess Health Care; 1994; 10(4):675-82. PubMed ID: 7843887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis.
    van Baal P; Meltzer D; Brouwer W
    Health Econ; 2016 Feb; 25(2):237-48. PubMed ID: 25533778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of health promotion: friend or foe?
    Richardson J
    Aust N Z J Public Health; 1998 Apr; 22(2):247-53. PubMed ID: 9744186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
    Birch S; Gafni A
    J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discounting in cost-utility analysis of healthcare interventions: reassessing current practice.
    Cohen BJ
    Pharmacoeconomics; 2003; 21(2):75-87. PubMed ID: 12515570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Packaging health services when resources are limited: the example of a cervical cancer screening visit.
    Kim JJ; Salomon JA; Weinstein MC; Goldie SJ
    PLoS Med; 2006 Nov; 3(11):e434. PubMed ID: 17105337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?].
    Margier J; Baffert S; Le Corroller-Soriano AG;
    Rev Epidemiol Sante Publique; 2018 Mar; 66 Suppl 2():S93-S99. PubMed ID: 29526356
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.